Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from ImExHS Limited ( (AU:IME) ) is now available.
ImExHS Limited announced a change in the director’s interest, with Douglas Lingard acquiring additional securities. The acquisition includes 37,356 nil price options and 542,858 fully paid ordinary shares, reflecting a strategic move under the Long-Term Incentive Plan and Conditional Placement. This change is expected to impact the company’s stock and stakeholder interests positively.
The most recent analyst rating on (AU:IME) stock is a Buy with a A$1.15 price target. To see the full list of analyst forecasts on ImExHS Limited stock, see the AU:IME Stock Forecast page.
More about ImExHS Limited
ImExHS Limited operates in the medical imaging industry, providing advanced imaging solutions and services. The company focuses on delivering innovative technologies to enhance diagnostic capabilities and improve patient outcomes.
Average Trading Volume: 23,833
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$18.24M
For a thorough assessment of IME stock, go to TipRanks’ Stock Analysis page.